This inventor holds 1 USPTO granted patent. Top assignee: Nisshin Chemicals Co., Ltd.. Active years: 1986.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1986
Title: Hiroyuki Sano: Innovator in Soft Capsule Technology
Introduction
Hiroyuki Sano is a notable inventor based in Ueda, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of soft capsule formulations. His innovative work has led to advancements that enhance the stability and efficacy of active ingredients in soft capsules.
Latest Patents
Hiroyuki Sano holds a patent for an "Oryzanol-containing soft capsule." This invention features a soft capsule that contains gamma-oryzanol as the active ingredient, either alone or in combination with riboflavin butyrate. The formulation is designed to increase the shelf life of the composition without causing precipitation of the ingredients. This advancement is crucial for maintaining the quality and effectiveness of the product over time.
Career Highlights
Sano is associated with Nisshin Chemicals Co., Ltd., where he has been instrumental in research and development. His work focuses on creating innovative solutions that address challenges in the pharmaceutical industry. His dedication to improving product formulations has positioned him as a key figure in his field.
Collaborations
Hiroyuki Sano has collaborated with Takeo Iijima, a fellow innovator, to further enhance their research efforts. Their partnership has contributed to the development of new technologies and formulations that benefit the industry.
Conclusion
Hiroyuki Sano's contributions to soft capsule technology exemplify the impact of innovation in pharmaceuticals. His patent for the oryzanol-containing soft capsule showcases his commitment to improving product stability and efficacy. Through his work at Nisshin Chemicals Co., Ltd., Sano continues to influence the future of pharmaceutical formulations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile